Wells Fargo & Company KYVERNA THERAPEUTICS INC Transaction History

Wells Fargo & Company

  • $468 Billion
  • Q2 2025
Number of Shares
3,332
Previous 16,678 80.02%
Holding current value
$0
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 14, 2025
SELL
N/A
-13,346 Reduced 80.02%
3,332 $0
Q1 2025

May 13, 2025
SELL
N/A
-162,334 Reduced 90.68%
16,678 $0
Q4 2024

Feb 12, 2025
BUY
N/A
25,225 Added 16.4%
179,012 $0
Q3 2024

Nov 13, 2024
BUY
N/A
41,078 Added 36.45%
153,787 $0
Q2 2024

Aug 13, 2024
BUY
N/A
100,803 Added 846.66%
112,709 $0
Q1 2024

May 10, 2024
BUY
N/A
11,906 New
11,906 $0
Track This Portfolio

Track Wells Fargo & Company Portfolio

Follow Wells Fargo & Company and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email